TOPICS

Tag: lidose-isotretinoin

Lidose-Isotretinoin Administered Without Food Improves Quality of Life in Patients With Severe Recalcitrant Nodular Acne: An Open-Label, Single-Arm, Phase IV Study

J Clin Aesthet Dermatol. 2020;13(9):15–20 by Andrea L. Zaenglein, MD; Jeanett Segal, MD; Charles Darby, MSc; and James Q. Del Rosso, DO Dr. Zaenglein is with Departments of Dermatology and Pediatrics at Penn State College of Medicine, Hershey Medical Center in Hershey, Pennsylvania. Dr. Segal is with Sun Pharmaceutical Industries, Inc., in Princeton, New Jersey.

CONTINUE READING »

An Open-label, Phase IV Study Evaluating Lidose-isotretinoin Administered without Food in Patients with Severe Recalcitrant Nodular Acne: Low Relapse Rates Observed Over the 104-week Post-treatment Period

 J Clin Aesthet Dermatol. 2019;12(11):13–18 by James Q. Del Rosso, MD; Linda Stein Gold, MD; Jeanett Segal; and Andrea L. Zaenglein, MD Dr. Del Rosso is with JDR Dermatology Research/Thomas Dermatology in Las Vegas, Nevada. Dr. Stein Gold is with the Department of Dermatology, Clinical Research Division at the Henry Ford Hospital in Detroit, Michigan. Dr.

CONTINUE READING »